Abbott Laboratories closed 8.06% below its 52-week high of $141.23, which the company reached on March 4th.

Abbott Laboratories closed 6.73% below its 52-week high of $141.23, which the company achieved on March 4th.

Texas Gov. Greg Abbott signed a bill into law that would create an organization similar to DOGE for the state. Abbott said ...

In a report released today, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions ...

Argus Research analyst David Toung maintained a Buy rating on Abbott Laboratories (ABT – Research Report) on April 17. The company’s shares ...

The ABBOTT PRISM System is an automated immunoassay ... technology is now being used in most major hospitals and reference laboratories and is now available in the transfusion market.

Abbott Laboratories has a 1 year low of $99.71 and a 1 year high of $141.23. The company has a market capitalization of $227.20 billion, a price-to-earnings ratio of 17.12, a P/E/G ratio of 2.52 ...

Abbott Laboratories (NYSE:ABT – Free Report) had its price target increased by Wells Fargo & Company from $136.00 to $147.00 in a research note issued to investors on Thursday morning ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...